Results 11 to 20 of about 88,630 (306)

Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B

open access: yesPharmaceutics
Background/Objectives: Hemophilia B is a hereditary bleeding disorder due to the production of liver malfunctional factor IX (FIX). Gene therapy with viral vectors offers a cure.
Brijesh Lohchania   +5 more
doaj   +2 more sources

Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm

open access: yesInternational Journal of Nanomedicine, 2011
Shuyu Xie1,*, Baoliang Pan1,*, Baoxin Shi2, Zhuangzhi Zhang2, Xu Zhang2, Ming Wang1, Wenzhong Zhou11Department of Preventive Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing, People’s Republic of China;
Xie S   +6 more
doaj   +1 more source

Lipid nanoparticles for mRNA delivery [PDF]

open access: yesNature Reviews Materials, 2021
Messenger RNA (mRNA) has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable delivery systems that protect the nucleic acid from degradation and that allow cellular uptake and mRNA release.
Xucheng Hou   +3 more
openaire   +2 more sources

Nanoparticle-Engendered Rupture of Lipid Membranes

open access: yes, 2018
Tension-induced rupture of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) lipid membranes with encapsulated hydrophobic nanoparticles is elucidated using dissipative particle dynamics simulations.
Christopher Tsovko (5625479)   +3 more
core   +3 more sources

From lipids to lipid nanoparticles to mRNA vaccines [PDF]

open access: yesNature Reviews Materials, 2021
Lipid nanoparticles are essential to mRNA vaccines. The groundwork for lipid-based drug delivery systems was laid more than 40 years ago in the lab of Pieter Cullis, Professor at the University of British Columbia. Nature Reviews Materials talks to Pieter Cullis about the history and future of lipid nanoparticle-nucleic acid drugs.
openaire   +2 more sources

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics

open access: yesPharmaceuticals, 2023
In biomedical applications, nanomaterial-based delivery vehicles, such as lipid nanoparticles, have emerged as promising instruments for improving the solubility, stability, and encapsulation of various payloads.
Tetiana Korzun   +7 more
doaj   +1 more source

LIPID AND SILVER NANOPARTICLES GELS FORMULATION OF TEMPEH EXTRACT

open access: yesJurnal Farmasi Sains dan Komunitas, 2020
Tempeh extract is used in this study as an active ingredient in lipid nanoparticles and reductant in silver nanoparticles because tempeh is an authentic Indonesian food ingredient and is known to have the main content of isoflavones.
Felicia Satya Christania   +2 more
doaj   +1 more source

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review

open access: yesPharmaceutics, 2023
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures. These nanocarriers may enhance the solubility and permeability of drugs,
Cláudia Viegas   +5 more
doaj   +1 more source

Challenges in the Physical Characterization of Lipid Nanoparticles [PDF]

open access: yesPharmaceutics, 2021
Nano-sized drug transporters have become an efficient approach with considerable commercial values. Nanomedicine is not only limited to drug delivery by means of different administration routes, such as intravenous, oral, transdermal, nasal, pulmonary, and more, but also has applications in a multitude of areas, such as a vaccine, antibacterial ...
Supandeep Singh Hallan   +3 more
openaire   +3 more sources

Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems

open access: yesPharmaceutics, 2023
Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of efficacy of existing treatments, research and development of innovative ...
Cláudia Viegas   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy